PINC Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 360 in its November 10, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
